2nd Advanced Course on the Pharmacological Treatment of Drug Resistant Epilepsies (DRE): From Rare to Common Epilepsies

It is our pleasure to announce the "2nd Advanced Course on the Pharmacological Treatment of Drug Resistant Epilepsies: From Rare to Common Epilepsies" that will take place in Palma de Mallorca, Spain, from 8 to 10 November 2024.

The objective of the course is to offer an update on current and future pharmacological treatments and strategies for drug-resistant epilepsies. The target audience is physicians and basic scientists willing to increase their knowledge on how to improve the treatment of these most challenging epilepsies. The audience will be encouraged to actively participate through case discussions.

The island of Mallorca and the city of Palma de Mallorca are an amazing frame that will surely enhance interaction between alumni and teachers during this three-day course.

We look forward to seeing you soon in Mallorca!

The course directors,

Dr. Jose M Serratosa Fernández, Epilepsy Unit and Department of Neurology, Fundación Jiménez Díaz University Hospital, Madrid (Spain)

Dr. Bernhard J Steinhoff, Professor of Neurology and Clinical Neurophysiology, University of Freiburg; Medical Director, Kork Epilepsy Center, Kehl-Kork (Germany)

Dr. Manuel Toledo Argany, Director, Epilepsy Unit, Vall d'Hebrón University Hospital, Barcelona (Spain)

Dr. Torbjörn Tomson, Senior Professor of Neurology and Epileptology, Department of Clinical Neuroscience, Karolinska Institutet (Sweden)

Organizer: Spanish Epilepsy Society

Registration

In-person attendance: 1600 euros

Registration fee includes access to the course, accommodation at Hotel Melia Palma Marina ****  2 nights in double room/single occupancy breakfast included, coffees and meals and reception dinner on 8 November.

A very limited number of bursaries are available, travel excluded. Please contact info@drugsresistantepilepsy.com.

Faculty

Mar Carreño, Hospital Clinic, Barcelona
Jacqueline French, NYU Grossman School of Medicine, New York
Elena Gardella, Danish Epilepsy Center and University of Southern Denmark, Dianalund
Cecilie Johannessen Landmark, Oslo University Hospital, Oslo
Andres M Kanner, University of Miami Miller School of Medicine, Miami
Heidrun Potschka, Ludwig-Maximilians-University, Munich
Guido Rubboli, Institute of Clinical Medicine, University of Copenhagen, Danish Epilepsy Center, Dianalund
Javier Salas, Hospital Universitario Vall d’Hebron, Barcelona
Jose M Serratosa, Hospital Universitario Fundación Jiménez Díaz, Madrid
Bernhard J Steinhoff, Diakonie Epilepsiezentrum, Kork
Manuel Toledo, Hospital Universitario Vall d’Hebron, Barcelona
Torbjörn Tomson, Karolinska Institute, Stockholm
Eugen Trinka, Paracelsus University, Salzburg